Free Trial
OTCMKTS:RCAR

RenovaCare (RCAR) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
RCAR stock logo

About RenovaCare Stock (OTCMKTS:RCAR)

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.

RCAR Stock News Headlines

RenovaCare Inc.
RenovaCare, Inc. (RCAR)
The solution to fast food’s wage hike crisis
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.
Best Midsize Car for 2022
Cheapest Car Insurance New Jersey
The solution to fast food’s wage hike crisis
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.
See More Headlines
Receive RCAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RenovaCare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
9/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:RCAR
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-100.95
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Key Executives

  • Mr. Harmel S. Rayat (Age 63)
    President, CEO, CFO, Interim Secretary & Chairman of the Board
  • Dr. Robin A. Robinson Ph.D. (Age 68)
    Chairman of Scientific Advisory Board, VP & Chief Scientific Officer
    Comp: $220k
  • Mr. Justin Frere CPA (Age 51)
    M.B.A., Treasurer
    Comp: $208.08k
  • Dr. Jo Ellen Schweinle M.D.
    Chief Medical Officer

RCAR Stock Analysis - Frequently Asked Questions

How do I buy shares of RenovaCare?

Shares of RCAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of RenovaCare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that RenovaCare investors own include Brainstorm Cell Therapeutics (BCLI), ReNeuron Group (RENE), Fulcrum Therapeutics (FULC), SCYNEXIS (SCYX), Teva Pharmaceutical Industries (TEVA), Akebia Therapeutics (AKBA) and Advanced Micro Devices (AMD).

This page (OTCMKTS:RCAR) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners